Bayer, J & J win first trial over Xarelto bleeding risks

(Reuters) - A federal jury has cleared Bayer AG and Johnson& Johnson of liability in the first trial to flow out of thousands of lawsuits blaming injuries on the blood thinner Xarelto, the drugmakers said on Wednesday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news